Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide

Clinical Endocrinology

Volumn 68, Issue 6, 2008, Pages 970-975

  Karavitaki, N ^a   Turner, H E ^a   Adams, C B T ^b   Cudlip, S ^b   Byrne, J V ^b   Fazal Sanderson, V ^a   Rowlers, S ^c   Trainer, P J ^c   Wass, J A H ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; CABERGOLINE; GROWTH HORMONE; OCTREOTIDE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE CONTROL; DRUG DOSE INCREASE; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS ADENOMA; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME; TUMOR VOLUME;

ACROMEGALY; ADENOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PITUITARY NEOPLASMS; SOMATOSTATIN; YOUNG ADULT;

EID: 43949139603     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.03139.x     Document Type: Article

References (16)